DNMT3A and B-cell chronic lymphocytic leukemia: A B-cell-restricted Dnmt3a knockout mouse model demonstrated that loss of DNMT3A expression was able to drive the development of CLL and was related to aggressive disease, Notch and Myc signaling activation, and Notch inhibition sensitivity enhancement [36].